For men with localized low-risk prostate cancer, there is no rush to decide on a treatment option, according to the National Prostate Cancer Register (NPCR) of Sweden Follow-up Study published online in the Journal of Urology. This suggestion is based on findings that after median follow-up of 8 years, men who underwent prompt radical prostatectomy had no significant difference in the presence of one of three adverse pathology features or in prostate cancer–specific mortality than men who deferred surgery for up to 19 months.
